Azathioprine and TPMT Testing: Why This Blood Test Prevents Severe Side Effects

You’ve been prescribed Azathioprine, a powerful immunosuppressant used to treat inflammatory bowel disease (IBD), autoimmune disorders, and organ transplant rejection. It’s an older drug, introduced in the 1960s, but it remains a cornerstone of treatment because it is effective and significantly cheaper than newer biologic agents. However, this medication carries a serious risk for a small percentage of patients: severe, potentially life-threatening bone marrow suppression.

Before you start taking azathioprine, your doctor should order a specific genetic test called TPMT testing. This test checks how your body metabolizes the drug. If you have certain genetic variations, standard doses can cause your white blood cell count to drop dangerously low, leaving you vulnerable to infections that could be fatal. Understanding this test isn’t just about following medical advice; it’s about protecting your health while getting the benefits of the medication.

What Is Azathioprine and How Does It Work?

Azathioprine belongs to a class of drugs known as thiopurines. When you take it, your body converts it into active compounds that interfere with DNA synthesis in rapidly dividing cells. This mechanism is what makes it effective at calming overactive immune systems in conditions like Crohn’s disease and ulcerative colitis. However, this same mechanism affects all rapidly dividing cells, including those in your bone marrow that produce blood cells.

The problem arises because people process this drug differently. The enzyme responsible for breaking down thiopurines is called thiopurine methyltransferase (TPMT). If you have high levels of this enzyme, the drug is broken down quickly and safely. If you have low or no TPMT activity, the active drug builds up in your system, leading to toxicity. This variation is genetic, meaning you are born with it, and it does not change over time.

Understanding TPMT Testing: Genotype vs. Phenotype

There are two ways doctors check your TPMT status: genotyping and phenotyping. Both aim to determine your risk level, but they work differently.

• Genotyping: This is the most common method today. A lab analyzes your DNA to look for specific gene variants (such as *2, *3A, *3B, and *3C) that reduce enzyme function. It is accurate, quick, and not affected by recent medical procedures.
• Phenotyping: This measures the actual amount of TPMT enzyme in your red blood cells. While direct, it can give false results if you have had a blood transfusion recently, as donor blood may have different enzyme levels.

Most clinics prefer genotyping because it provides clear, actionable data without the interference of external factors like transfusions. The test typically costs between $200 and $400 in the United States, with results available within 3 to 7 days. Many insurance plans cover this cost because preventing a hospitalization for severe neutropenia is far cheaper than treating one.

Your TPMT Results: What Do They Mean for Your Dose?

Your test result will fall into one of three categories. Each category dictates a specific dosing strategy recommended by the Clinical Pharmacogenetics Implementation Consortium (CPIC).

If you have intermediate activity, you aren’t barred from taking the drug. You just need a lower starting point. For example, instead of starting at 100mg daily, your doctor might begin with 50mg or even less, increasing the dose gradually only if your blood tests remain stable. This approach allows many heterozygous patients to achieve therapeutic benefits without suffering severe side effects.

The Critical Role of NUDT15 Testing

While TPMT testing is essential, it doesn’t tell the whole story for everyone. Recent guidelines from CPIC (updated in 2022) now emphasize testing for another gene called NUDT15.

NUDT15 deficiency is particularly prevalent in Asian populations, affecting up to 20% of individuals in some groups. In these patients, NUDT15 variants account for a larger proportion of azathioprine toxicity cases than TPMT variants do. If you have East Asian ancestry, asking about NUDT15 testing is crucial. Like TPMT, NUDT15 helps regulate thiopurine metabolism, and its absence leads to the same dangerous buildup of toxic metabolites.

Many modern pharmacogenomic panels now include both TPMT and NUDT15. If your initial test only covered TPMT, discuss whether adding NUDT15 screening is appropriate for your ethnic background and personal risk profile.

Why Testing Isn't a Substitute for Blood Monitoring

Here is a critical misconception: having a normal TPMT test does not make you immune to side effects. Even patients with normal enzyme activity can experience adverse reactions. Studies show that adverse effects occur in 15% to 28% of all azathioprine users. Common issues include nausea, liver toxicity (hepatotoxicity), and pancreatitis, which are not always predicted by TPMT status alone.

Therefore, Complete Blood Count (CBC) monitoring is non-negotiable. You must get regular blood tests, especially during the first few months of treatment. The American Gastroenterological Association (AGA) stresses that CBC and liver function tests must continue regardless of your genetic test results. If your white blood cell count drops unexpectedly, your doctor will likely reduce the dose or stop the medication immediately, even if your TPMT status was normal.

Drug Interactions That Increase Risk

Your genetics are only part of the equation. Certain medications can interact with azathioprine, effectively blocking its breakdown pathways and mimicking a TPMT deficiency. The most notable interaction is with Allopurinol, a drug commonly used to treat gout.

Allopurinol inhibits xanthine oxidase, another enzyme involved in azathioprine metabolism. Taking both together can increase azathioprine toxicity risk regardless of your TPMT status. If you are on allopurinol, your doctor must reduce your azathioprine dose significantly-often by 75%-and monitor you closely. Other drugs, such as certain ACE inhibitors, may also influence toxicity risks, so always provide your healthcare provider with a complete list of all medications and supplements you take.

When to Seek Immediate Medical Attention

Knowing the signs of severe side effects can save your life. Contact your doctor immediately if you experience any of the following symptoms after starting azathioprine:

• Fever or chills (signs of infection due to low white blood cells)
• Unusual bruising or bleeding (signs of low platelets)
• Extreme fatigue or shortness of breath (signs of anemia)
• Persistent nausea or vomiting
• Abdominal pain, especially in the upper left side (potential pancreatitis)
• Yellowing of the skin or eyes (jaundice, indicating liver stress)

Do not wait for your next scheduled appointment. Severe myelosuppression can develop rapidly, particularly in the first four weeks of treatment. Early intervention often means simply stopping the drug temporarily, allowing your blood counts to recover, and then restarting at a lower dose under strict supervision.

Alternatives to Azathioprine

If you have deficient TPMT or NUDT15 activity, or if you cannot tolerate azathioprine despite dose adjustments, there are other options. Biologic agents like infliximab or adalimumab are highly effective for IBD and autoimmune conditions but come at a much higher cost ($1,500-$2,500 per dose compared to $20-$50 monthly for azathioprine). Other immunosuppressants like methotrexate or cyclosporine may be considered depending on your specific condition and overall health profile. Discuss these alternatives with your specialist to find a balance between efficacy, safety, and affordability.